Financial Data and Key Metrics Changes - For Q1 of fiscal 2026, total revenue was $120.9 million, a slight increase of $1 million or 0.8% from $119.9 million in Q1 of fiscal 2025, primarily driven by increased DSA revenue and partially offset by decreased RMS revenue [12][19] - DSA revenue increased to $48 million from $42.8 million, representing a year-over-year growth of 12%, with discovery pharmacology service and surgical services contributing significantly [5][12] - RMS revenue decreased by $4.1 million or 5.4% to $72.9 million, primarily due to lower NHP volumes sold [14][15] - The overall operating loss increased to $16.3 million from $15.5 million, driven by a higher RMS operating loss [16][19] - Consolidated net loss totaled $28.4 million or $0.83 loss per diluted share, compared to a net loss of $27.6 million or $1.02 loss per diluted share in the prior year [18][19] Business Line Data and Key Metrics Changes - DSA business saw strong growth with net new awards of $53.6 million, a 27% increase over Q1 of fiscal 2025, and a trailing twelve-month increase of 34% [13] - DSA margins improved, with non-GAAP operating income for the DSA segment at $8.2 million or 6.8% of total revenue, up from $7.1 million or 5.9% [17] - RMS segment's non-GAAP operating income decreased to $7.2 million or 5.9% of total revenue, down from $9.4 million or 7.9% due to lower NHP volume sales [18] Market Data and Key Metrics Changes - The book-to-bill ratio for DSA in Q1 of fiscal 2026 was 1.16 to 1, with a trailing twelve-month book-to-bill of 1.08 to 1 [14] - DSA backlog increased to $145.4 million at December 31, 2025, compared to $138.2 million at September 30, 2025 [14] Company Strategy and Development Direction - The company is focused on improving revenue and margins in the DSA business while reducing costs and diversifying revenue sources in the RMS business [10] - The company is enhancing its NAM strategy to support FDA guidance and industry expectations for innovation, with recent collaborations aimed at integrating advanced machine learning tools [10][50] - The company is committed to optimizing its operational footprint and product portfolio while maintaining client satisfaction [11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the DSA business's momentum and the ongoing site optimization and cost reduction initiatives in the RMS business [9] - The company is navigating macroeconomic factors affecting the RMS business and remains committed to refinancing its debt and improving its balance sheet [9][20] - Management anticipates continued improvement in margins and revenue growth in the DSA segment as pricing stabilizes and operational efficiencies are realized [26][31] Other Important Information - The company engaged Perella Weinberg Partners for financial advisory services to explore debt refinancing alternatives [9] - Capital expenditures for Q1 of 2026 were $5.2 million, with expectations to keep annual CapEx below 4% of revenue [21][22] Q&A Session Summary Question: Can you provide more details on profitability and adjusted EBITDA trends? - Management noted that seasonality impacts the first quarter, and increased operating expenses were observed, particularly in cost of goods sold [25][26] Question: What is the outlook for DSA awards and growth? - Management highlighted that DSA growth is supported by improved customer relationships and scientific strength, with expectations for continued positive trends [28][30] Question: Can you explain the recent decline in RMS revenue and operating leverage? - Management indicated that reduced NHP volumes overshadowed operating leverage benefits, but cost reductions from facility closures are expected to yield improvements in future quarters [38][40] Question: How are recent weather conditions impacting operations and costs? - Management confirmed that weather impacts shipping and operations, but the overall cost impact is not significant [51][52]

PowerFleet (NasdaqGM:AIOT) Q3 2026 Earnings call February 09, 2026 08:30 AM ET Company ParticipantsCarolyn Capaccio - SVPDavid Wilson - CFOGary Prestopino - Managing DirectorJeff Lautenbach - Chief Revenue OfficerSteve Towe - CEOConference Call ParticipantsAlexander Sklar - Equity Research AnalystDylan Becker - Equity Research AnalystGreg Gibas - Senior Research AnalystScott Searle - Senior Research AnalystOperatorPlease note this conference is being recorded. I will now turn the conference over to your hos ...

Frank Takkinen - Senior Research Analyst Matt Hewitt - Senior Research Analyst Operator Please be advised that today's call is being recorded. We are standing by should you need any assistance. I'd now like to turn the call over to Steve Halper with LifeSci Advisors. Please go ahead. Steve Halper Thank you, Jamie, and good morning, everyone. Thank you for joining today's quarterly call with Inotiv's management team. Before we begin, I'd like to remind everyone that some of the statements that management wil ...

PowerFleet (NasdaqGM:AIOT) Q3 2026 Earnings call February 09, 2026 08:30 AM ET Company ParticipantsCarolyn Capaccio - SVPDavid Wilson - CFOGary Prestopino - Managing DirectorJeff Lautenbach - Chief Revenue OfficerSteve Towe - CEOConference Call ParticipantsAlexander Sklar - Equity Research AnalystDylan Becker - Equity Research AnalystGreg Gibas - Senior Research AnalystScott Searle - Senior Research AnalystOperatorPlease note this conference is being recorded. I will now turn the conference over to your hos ...

Financial Data and Key Metrics Changes - The company reported revenue of $3.9 billion for the third quarter, reflecting a 3% increase year-over-year on a reported basis, unchanged in constant currency [15][16] - Adjusted EBITDA decreased by 1% year-over-year to $696 million, while Adjusted Pre-Tax Income grew by 5% year-over-year to $168 million [16][18] - Free cash flow generated in the third quarter was $217 million, with a net CapEx of $210 million [18][19] Business Line Data and Key Metrics Changes - Kyndryl Consult experienced a strong performance with a 20% year-over-year growth in constant currency, now representing 25% of total revenue [15][16] - Hyperscaler-related revenue reached $500 million in the third quarter, marking a 58% increase year-over-year, exceeding initial growth expectations [17] - The company signed contracts totaling $3.9 billion in the quarter, with a trailing 12-month revenue book-to-bill ratio remaining above 1.0 [5][16] Market Data and Key Metrics Changes - The company noted a slowdown in attrition rates, particularly in strategic markets and the UK, which has led to increased local hiring costs [31][32] - The evolving partnership with IBM has resulted in a significant reduction in annualized spend from nearly $4 billion to approximately $2 billion, impacting revenue growth [9][58] Company Strategy and Development Direction - The company is focused on expanding its capabilities in AI and private cloud services, responding to increased demand driven by data sovereignty and security requirements [12][66] - The strategic direction emphasizes the importance of long-term customer relationships and adapting to changing market dynamics [13][66] - The company aims to achieve fiscal 2028 targets, projecting approximately $1.1 billion in Adjusted Pre-Tax Income and over $1 billion in adjusted free cash flow [14][23] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that longer sales cycles and evolving customer consumption models are impacting revenue expectations [24][28] - The company remains confident in its growth strategy despite current challenges, emphasizing the importance of adapting to industry disruptions caused by AI and regulatory changes [7][39] - Management reiterated that they do not expect a restatement of financial statements despite ongoing SEC reviews [25][36] Other Important Information - The company has repurchased 3.7 million shares in the quarter, representing 1.6% of outstanding shares, as part of its capital allocation strategy [18][19] - The financial position remains strong with a cash balance of $1.35 billion and a net leverage ratio of 0.7x Adjusted EBITDA [20][21] Q&A Session Summary Question: Outlook and Revision Factors - Analysts inquired about the reasons behind the revised outlook, focusing on sales cycle delays and the evolving IBM partnership [27][28] - Management explained that the sales cycles have lengthened due to market dynamics and regulatory discussions, impacting growth expectations [28][29] Question: Strategic Market Changes - Questions were raised regarding changes in strategic markets, particularly in the UK, and the associated costs and benefits [30][31] - Management indicated that investments in local markets are necessary but may take time to yield results [31][32] Question: Free Cash Flow and Working Capital - Analysts sought clarification on the factors affecting free cash flow projections, particularly in relation to pre-tax income revisions [49][50] - Management confirmed that the primary driver of the change in free cash flow guidance is linked to the revision in pre-tax income [50] Question: Confidence in Fiscal 2028 Targets - Questions were posed about the building blocks supporting confidence in achieving fiscal 2028 targets despite current shortfalls [56][57] - Management highlighted the importance of cash flow growth, profitability improvements, and the shift towards higher-margin contracts as key factors [58][59]

Kyndryl (NYSE:KD) Q3 2026 Earnings call February 09, 2026 08:30 AM ET Company ParticipantsHarsh Chugh - Interim CFOIan Zaffino - Managing DirectorJames Faucette - Managing DirectorJonathan Lee - Managing DirectorLori Chaitman - Global Head of Investor RelationsMartin Schroeter - Chairman and CEOConference Call ParticipantsJames Friedman - Senior AnalystTien-tsin Huang - Managing Director and Senior AnalystOperatorPlease be advised that today's conference is being recorded. I would now like to hand the confe ...

Anavex Life Sciences (NasdaqGS:AVXL) Q1 2026 Earnings call February 09, 2026 08:30 AM ET Company ParticipantsChristopher Missling - President and CEOClint Tomlinson - VP of OperationsRam Selvaraju - Managing Director of Equity ResearchSandra Boenisch - Principal Financial OfficerConference Call ParticipantsJesse Silveira - AnalystTom Bishop - AnalystClint TomlinsonGood morning, everyone, and welcome to the Anavex Life Sciences fiscal 2026 first quarter conference call. My name is Clint Tomlinson, and I will ...

Financial Data and Key Metrics Changes - Total shipments in Q4 2025 were 3.8 million tons, slightly lower than Q3 due to seasonal impacts, with expectations to improve to 4 million tons in Q1 2026 [17] - Q4 price realization was $993 per net ton, down by approximately $40 per net ton, but expected to improve by about $60 per ton in Q1 2026 [18][22] - Unit costs decreased by $40 per ton in 2025, marking the third consecutive year of reductions, with further expectations of a $10 per ton decrease in 2026 [19] Business Line Data and Key Metrics Changes - The company has shifted melting capacity from low-margin slabs to higher-margin flat-rolled products, anticipating continued demand for domestically produced slabs [5] - The automotive sector remains the core end market, with multi-year fixed-price contracts signed with major OEMs, expected to enhance market share and profitability in 2026 [7][9] Market Data and Key Metrics Changes - The spot steel price is at a two-year high, benefiting from Section 232 tariffs and increased domestic production [6] - Canadian pricing and shipments have improved following government restrictions on imported steel, positively impacting the Canadian subsidiary, Stelco [12] Company Strategy and Development Direction - The company is focused on leveraging existing production capacity without the need for new plants, positioning itself to benefit from the anticipated increase in domestic automotive production [8][10] - A strategic partnership with POSCO is a top priority, aimed at enhancing collaboration and meeting U.S. trade requirements [14][53] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the improving business environment, citing a solid order book, rising prices, and declining costs as key factors for 2026 [22] - The company is well-positioned to capitalize on the return of vehicle production to pre-COVID levels, with expectations of significant throughput and profitability gains [23] Other Important Information - The company achieved a record low total recordable incident rate in 2025, reflecting a 43% improvement compared to 2021 [15] - Capital expenditures in 2025 were $561 million, with projections for 2026 to be around $700 million, reflecting normalized maintenance spending [20] Q&A Session Summary Question: Expected benefits from the cancellation of the slab contract - Management anticipates an EBITDA improvement of approximately $500 million from the cancellation of the slab contract, with benefits expected to materialize more significantly in Q2 2026 [27][31] Question: CapEx expectations beyond 2026 - CapEx is projected to be $700 million in 2026, increasing to $900 million in 2027 due to a blast furnace reline, then returning to $700 million in 2028 [34] Question: Open capacity and potential for contracting - The company has significant downstream capacity available, with the ability to produce specialized steel products, contingent on increased domestic automotive production [39][41] Question: Outlook for Q1 2026 - Shipments are expected to return to 4 million tons in Q1 2026, with ASP projected to increase by $60 per ton, driven by improved demand and pricing dynamics [44][46] Question: Impact of Stelco on earnings - Stelco's performance in 2025 was disappointing, but improvements are expected in 2026 as Canadian market dynamics change, contributing positively to overall results [60][64]

Sally Beauty Holdings (NYSE:SBH) Q1 2026 Earnings call February 09, 2026 08:30 AM ET Company ParticipantsAlec Legg - VP and Equity ResearchDenise Paulonis - President and CEOJeff Harkins - VP of Investor Relations and TreasurerLauren Ng - Equity Research AssociateOliver Chen - Managing DirectorSydney Wagner - Equity Research Senior AssociateConference Call ParticipantsOlivia Tong - Managing Director and Senior AnalystOperatorGood morning, everyone, and welcome to the Sally Beauty Holdings conference call to ...

Apollo Global Management (NYSE:APO) Q4 2025 Earnings call February 09, 2026 08:30 AM ET Speaker4 Good morning and welcome to Apollo Global Management's fourth quarter 2025 earnings conference call. During today's discussion, all callers will be placed in listen-only mode, and following management's prepared remarks, the conference call will be opened for questions. Please limit yourself to one question, then rejoin the queue. This conference call is being recorded. This call may include forward-looking stat ...